Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing

Detalhes bibliográficos
Autor(a) principal: Nucci, Marcio
Data de Publicação: 2014
Outros Autores: Carlesse, Fabianne [UNIFESP], Cappellano, Paola [UNIFESP], Varon, Andrea G., Seber, Adriana [UNIFESP], Garnica, Marcia, Nouer, Simone A., Colombo, Arnaldo Lopes [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1371/journal.pone.0087784
http://repositorio.unifesp.br/handle/11600/37331
Resumo: Cross-reactivity of Fusarium species with serum galactomannan antigen (GMI) test has been observed. We sought to evaluate if GMI could help to early diagnose invasive fusariosis and to monitor treatment response. We reviewed the records of all patients with invasive fusariosis between 2008 and 2012 in three Brazilian hospitals. We selected patients who had at least 1 GMI test within 2 days before or after the date of the first clinical manifestation of fusariosis, and analyzed the temporal relationship between the first positive GMI test and the date of the diagnosis of invasive fusariosis, and the kinetics of GMI in relation to patients' response to treatment. We also selected 18 controls to determine the sensitivity and specificity of the test. Among 18 patients, 15 (83%) had at least one positive GMI (median 4, range 1-15). the sensitivity and specificity of was 83% and 67%, respectively. GMI was positive before the diagnosis of invasive fusariosis in 11 of the 15 cases (73%), at a median of 10 days (range 3-39), and after the diagnosis in 4 cases. GMI became negative in 8 of the 15 patients; 3 of these 8 patients (37.5%) were alive 90 days after the diagnosis of fusariosis compared with 2 of 7 (29%) who did not normalize GMI (p = 1.0). GMI is frequently positive in invasive fusariosis, and becomes positive before diagnosis in most patients. These findings may have important implications for the choice of antifungal therapy in settings with high prevalence of invasive fusariosis.
id UFSP_154d7835681a3612f3f22a1e154e6b44
oai_identifier_str oai:repositorio.unifesp.br/:11600/37331
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan TestingCross-reactivity of Fusarium species with serum galactomannan antigen (GMI) test has been observed. We sought to evaluate if GMI could help to early diagnose invasive fusariosis and to monitor treatment response. We reviewed the records of all patients with invasive fusariosis between 2008 and 2012 in three Brazilian hospitals. We selected patients who had at least 1 GMI test within 2 days before or after the date of the first clinical manifestation of fusariosis, and analyzed the temporal relationship between the first positive GMI test and the date of the diagnosis of invasive fusariosis, and the kinetics of GMI in relation to patients' response to treatment. We also selected 18 controls to determine the sensitivity and specificity of the test. Among 18 patients, 15 (83%) had at least one positive GMI (median 4, range 1-15). the sensitivity and specificity of was 83% and 67%, respectively. GMI was positive before the diagnosis of invasive fusariosis in 11 of the 15 cases (73%), at a median of 10 days (range 3-39), and after the diagnosis in 4 cases. GMI became negative in 8 of the 15 patients; 3 of these 8 patients (37.5%) were alive 90 days after the diagnosis of fusariosis compared with 2 of 7 (29%) who did not normalize GMI (p = 1.0). GMI is frequently positive in invasive fusariosis, and becomes positive before diagnosis in most patients. These findings may have important implications for the choice of antifungal therapy in settings with high prevalence of invasive fusariosis.Univ Fed Rio de Janeiro, Univ Hosp, Rio de Janeiro, BrazilUniversidade Federal de São Paulo UNIFESP, Inst Pediat Oncol GRAACC, São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Univ Hosp, São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Inst Pediat Oncol GRAACC, São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Univ Hosp, São Paulo, BrazilWeb of SciencePublic Library ScienceUniversidade Federal do Rio de Janeiro (UFRJ)Universidade Federal de São Paulo (UNIFESP)Nucci, MarcioCarlesse, Fabianne [UNIFESP]Cappellano, Paola [UNIFESP]Varon, Andrea G.Seber, Adriana [UNIFESP]Garnica, MarciaNouer, Simone A.Colombo, Arnaldo Lopes [UNIFESP]2016-01-24T14:35:10Z2016-01-24T14:35:10Z2014-01-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion5application/pdfhttp://dx.doi.org/10.1371/journal.pone.0087784Plos One. San Francisco: Public Library Science, v. 9, n. 1, 5 p., 2014.10.1371/journal.pone.0087784WOS000330510000149.pdf1932-6203http://repositorio.unifesp.br/handle/11600/37331WOS:000330510000149engPlos Oneinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-08T04:57:28Zoai:repositorio.unifesp.br/:11600/37331Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-08T04:57:28Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
title Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
spellingShingle Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
Nucci, Marcio
title_short Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
title_full Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
title_fullStr Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
title_full_unstemmed Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
title_sort Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
author Nucci, Marcio
author_facet Nucci, Marcio
Carlesse, Fabianne [UNIFESP]
Cappellano, Paola [UNIFESP]
Varon, Andrea G.
Seber, Adriana [UNIFESP]
Garnica, Marcia
Nouer, Simone A.
Colombo, Arnaldo Lopes [UNIFESP]
author_role author
author2 Carlesse, Fabianne [UNIFESP]
Cappellano, Paola [UNIFESP]
Varon, Andrea G.
Seber, Adriana [UNIFESP]
Garnica, Marcia
Nouer, Simone A.
Colombo, Arnaldo Lopes [UNIFESP]
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal do Rio de Janeiro (UFRJ)
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Nucci, Marcio
Carlesse, Fabianne [UNIFESP]
Cappellano, Paola [UNIFESP]
Varon, Andrea G.
Seber, Adriana [UNIFESP]
Garnica, Marcia
Nouer, Simone A.
Colombo, Arnaldo Lopes [UNIFESP]
description Cross-reactivity of Fusarium species with serum galactomannan antigen (GMI) test has been observed. We sought to evaluate if GMI could help to early diagnose invasive fusariosis and to monitor treatment response. We reviewed the records of all patients with invasive fusariosis between 2008 and 2012 in three Brazilian hospitals. We selected patients who had at least 1 GMI test within 2 days before or after the date of the first clinical manifestation of fusariosis, and analyzed the temporal relationship between the first positive GMI test and the date of the diagnosis of invasive fusariosis, and the kinetics of GMI in relation to patients' response to treatment. We also selected 18 controls to determine the sensitivity and specificity of the test. Among 18 patients, 15 (83%) had at least one positive GMI (median 4, range 1-15). the sensitivity and specificity of was 83% and 67%, respectively. GMI was positive before the diagnosis of invasive fusariosis in 11 of the 15 cases (73%), at a median of 10 days (range 3-39), and after the diagnosis in 4 cases. GMI became negative in 8 of the 15 patients; 3 of these 8 patients (37.5%) were alive 90 days after the diagnosis of fusariosis compared with 2 of 7 (29%) who did not normalize GMI (p = 1.0). GMI is frequently positive in invasive fusariosis, and becomes positive before diagnosis in most patients. These findings may have important implications for the choice of antifungal therapy in settings with high prevalence of invasive fusariosis.
publishDate 2014
dc.date.none.fl_str_mv 2014-01-28
2016-01-24T14:35:10Z
2016-01-24T14:35:10Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1371/journal.pone.0087784
Plos One. San Francisco: Public Library Science, v. 9, n. 1, 5 p., 2014.
10.1371/journal.pone.0087784
WOS000330510000149.pdf
1932-6203
http://repositorio.unifesp.br/handle/11600/37331
WOS:000330510000149
url http://dx.doi.org/10.1371/journal.pone.0087784
http://repositorio.unifesp.br/handle/11600/37331
identifier_str_mv Plos One. San Francisco: Public Library Science, v. 9, n. 1, 5 p., 2014.
10.1371/journal.pone.0087784
WOS000330510000149.pdf
1932-6203
WOS:000330510000149
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Plos One
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 5
application/pdf
dc.publisher.none.fl_str_mv Public Library Science
publisher.none.fl_str_mv Public Library Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268413119299584